MENU
+Compare
LQDA
Stock ticker: NASDAQ
AS OF
Nov 21 closing price
Price
$29.11
Change
+$0.55 (+1.93%)
Capitalization
2.53B

LQDA Liquidia Corp Forecast, Technical & Fundamental Analysis

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease... Show more

LQDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for LQDA with price predictions
Nov 21, 2025

LQDA in upward trend: price rose above 50-day moving average on November 03, 2025

LQDA moved above its 50-day moving average on November 03, 2025 date and that indicates a change from a downward trend to an upward trend. In of 35 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 30, 2025. You may want to consider a long position or call options on LQDA as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LQDA just turned positive on October 28, 2025. Looking at past instances where LQDA's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for LQDA crossed bullishly above the 50-day moving average on November 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LQDA advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 202 cases where LQDA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LQDA moved out of overbought territory on November 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where LQDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LQDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LQDA broke above its upper Bollinger Band on November 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LQDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (114.943) is normal, around the industry mean (27.248). P/E Ratio (0.000) is within average values for comparable stocks, (51.596). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.881). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (35.971) is also within normal values, averaging (320.415).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
LQDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

LQDA is expected to report earnings to fall 566.75% to 18 cents per share on March 12

Liquidia Corp LQDA Stock Earnings Reports
Q4'25
Est.
$0.19
Q3'25
Beat
by $0.37
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.07
The last earnings report on November 03 showed earnings per share of -3 cents, beating the estimate of -40 cents. With 2.17M shares outstanding, the current market capitalization sits at 2.53B.
A.I. Advisor
published General Information

General Information

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PZVSX12.770.53
+4.33%
Pzena Small Cap Value Investor
PFPFX56.691.11
+2.00%
Poplar Forest Partners A
TIOHX17.020.20
+1.19%
Nuveen International Opps I
FHJMX44.440.46
+1.05%
Fidelity Advisor Europe I
CGVYX27.420.22
+0.81%
American Funds Global Insight 529-A

LQDA and Stocks

Correlation & Price change

A.I.dvisor tells us that LQDA and ATOS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LQDA and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+1.93%
ATOS - LQDA
33%
Poorly correlated
+3.75%
DMAC - LQDA
32%
Poorly correlated
+5.68%
SRRK - LQDA
32%
Poorly correlated
+5.76%
KYMR - LQDA
32%
Poorly correlated
+2.18%
AXON - LQDA
32%
Poorly correlated
+0.46%
More